KILPEST

3B BlackBio Dx Share Price

 

 

Start SIP in KILPEST

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹1,442.01
  • 100 DMA₹1,434.32
  • 200 DMA₹1,465.13

Investment Returns

  • Over 1 Month + 15.2%
  • Over 3 Month + 16.07%
  • Over 6 Month + 7.52%
  • Over 1 Year -13.71%

Smart Investing Starts Here Start SIP with 3B BlackBio Dx for Steady Growth!

Invest Now

3B BlackBio Dx Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

3B BlackBio Dx Financials

3B BlackBio Dx Technicals

EMA & SMA

Current Price
₹1,636.55
-15.9 (-0.96%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,517.15
  • 50 Day
  • ₹1,442.01
  • 100 Day
  • ₹1,434.32
  • 200 Day
  • ₹1,465.13

Resistance and Support

1660.45 Pivot Speed
  • R3 1,762.80
  • R2 1,731.35
  • R1 1,691.90
  • S1 1,621.00
  • S2 1,589.55
  • S3 1,550.10

3B BlackBio Dx Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-28 Audited Results & Dividend
2025-02-13 Quarterly Results
2024-11-13 Quarterly Results
Date Purpose Remarks
2025-09-19 FINAL Rs.4.00 per share(40%)Dividend
View 3B BlackBio Dx Dividend History Arrow

3B BlackBio Dx F&O

3B BlackBio Dx Shareholding Pattern

No data available.

3B BlackBio Dx FAQs

3B BlackBio Dx share price is ₹1,636 As on 23 January, 2026 | 16:40

The Market Cap of 3B BlackBio Dx is ₹1404.6 Cr As on 23 January, 2026 | 16:40

The P/E ratio of 3B BlackBio Dx is 28.6 As on 23 January, 2026 | 16:40

The PB ratio of 3B BlackBio Dx is 4.7 As on 23 January, 2026 | 16:40

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23